oa SA Pharmaceutical Journal - Januvia®: sitagliptin for type 2 diabetes : drug info : new product focus
|Article Title||Januvia®: sitagliptin for type 2 diabetes : drug info : new product focus|
|© Publisher:||Medpharm Publications|
|Journal||SA Pharmaceutical Journal|
|Publication Date||Jan 2013|
|Pages||28 - 29|
Sitagliptin monotherapy, or as add-on therapy, is generally well tolerated with the additional benefit of causing weight loss in patients with type 2 diabetes. Sitagliptin also has a lower potential for hypoglycaemic events because of the glucose-dependent mechanism of action.
Article metrics loading...